Table 1.
Author(s) | Epidemiological Criteria | Clinical Features | References | |||||
---|---|---|---|---|---|---|---|---|
Country | Age | Sex | Clinical Manifestation | Location | Larvae Isolation/Observation * | Treatment | ||
James 1947 | USA | NA | NA | NA | Urogenital | NA | NA | [40] |
Tokunanga et al. 1953 | Japan | 48 | F | NA | Intestinal | NA | NA | [41] |
Zumpt 1965 | Germany | NA | NA | NA | Intestinal | Ingested food | NA | [42] |
Nevill et al. 1969 | Pretoria | Elderly | F | Movement felt in nose | Nasopharyngeal | Observed in discharged nose excretion | Application of insecticide strips for one month | [43] |
Mohammed and Smith 1976 | Nigeria | NA | M | Irritation in nose | Nasopharyngeal | Broughted by the patient | NA | [44] |
Smith and Thomas 1979 | Malaysia | 7 | M | Severe gastro-enteritis | Intestinal | Observed in the vomiting | NA | [45] |
Tu et al. 2007 | Taîwan | 21 | M | Abdominal pain and anal itching | Intestinal | Observed in stool sample | Anthelmintic mebendazol | [28] |
Hovius et al. 2011 | Netherland (Mexico) | 18 | F | No symptom | Urogenital | Observed in menses secretions | NA | [46] |
El-badry et al. 2014 | Egypt | NA | F | Dysuria, fever and itching in the periurethral and genital regions | Urogenital | Observed in urine sample | Antibiotic and antiseptic treatment | [21] |
Mokhtar et al. 2016 | Malaysia | 41 | F | No symptom | Intestinal | Observed in stool sample | Albendazole | [47] |
El-dib et al. 2017 | Egypt | 24 | F | Dysuria, pollakiuria | Urogenital | Observed in urine sample | Ivermectin | [48] |
Zhang et al. 2017 | China | 50 | F | Frequent micturition and urgency | Urogenital | Observed in urine sample | Broad-spectrum antibiotics for one week | [26] |
Hjaija et al. 2018 | Palestine | 28 | F | Abdominal pain with burning sensation in urinating | Urogenital | Observed in urine sample | Antibiotic and antiseptic therapy, pleniful hydratation | [27] |
Sarkar et al. 2018 | India | 40 | M | Lower abdominal pain with painful burning sensation during micturition | Urogenital | Observed in urine sample | Fluroquinolone | [25] |
Geremy-Depatureaux et al. 2019 | Canada | 57 | M | No symptom | Urogenital | Observed in urine sample | Ivermectin | [49] |
Fatima et al. 2019 | India | 24 | F | No symptom | Urogenital | Observed in urine sample | Ivermectin | [50] |
Farrag et al. 2019 | Egypt | 5–24 | M&F | Dysuria, frequency of micturition and genital pruritus | Urogenital | Observed in urine sample | Antibiotics and Ivermectin | [20] |
El-dib et al. 2020 | Egypt | 36 | M | Abdominal pain, bloating sensation, diarrhea intermittent with constipation, perianal itching, irritability and insomnia | Intestinal | Observed in stool sample | Ivermectin and Nanozoxide twice daily | [51] |
Gökçe et al. 2020 | Turkey | 43 | F | No symptom | Urogenital and gastrointestinal | Observed in stool and urine samples | NA | [52] |
Alshimmre and Ismail 2020 | Iraq | 34 | F | Mild dysuria | Urogenital | Laying eggs by female flies on the underwears | Antibiotics | [53] |
Chen et al. 2022 | China | 26 | F | No symptom | Oral myiasis | Isolated from residual dental root | Antibiotics and Ivermectin | [54] |
F: Female; M: Male; NA: Not Available; *: Observed by patient or isolated by treating physician.